ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
  • E-Cad Promotes Liver Tissue Formation in Hepatic Differentiation of Mouse Embryonic Stem Cells through Regulating the Differentiation Progress

    A. Hu, X. He

  • Early Acute Rejection (AR) Initiates Alloimmune Mechanisms Ultimately Leading to Kidney Graft Failure

    M. El Ters, M. Keddis, E. Rodrigo, A. Muriithi, M. Stegall, F. Cosio

  • Early and Late Reuse of Liver Allografts from Brain-Dead Liver Transplant Recipients

    C. Desai, K. Shetty, K. Khan, R. Girlanda, C. Matsumoto, T. Fishbein

  • Early Antibody-Mediated Rejection Portends Worse Long-Term Renal Graft and Patient Survival

    B. Orandi, E. Chow, K. Van Arendonk, J. Montgomery, N. Gupta, R. Montgomery, D. Segev

  • Early Bacterial Infections in Simultaneous Kidney and Pancreas Transplantation: Impact of Preservation Fluid Contamination

    E. Morelon, D. Chaintreuil, T. Benet, M. Reverdy, M. Brunet, F. Buron, C. Chauvet, S. Daoud, O. Thaunat, P. Vanhems, L. Badet

  • Early BK Viremia Is Associated with Antibodies to Kidney Transplant-Associated Self-Antigens Collagen Type IV and Fibronectin

    M. Seifert, C. Klein, D. Brennan, T. Mohanakumar

  • Early Complications after ABO Incompatible Kidney Transplantation: A National Database Study

    K. Lentine, D. Axelrod, C. Simpkins, H. Xiao, J. Tuttle-Newhall, M. Schnitzler, V. Dharnidharka, D. Brennan, D. Segev

  • Early Elevated Everolimus Levels Are Associated with More Toxicities without Improved Efficacy

    D. Taber, L. Belk, J. McGillicuddy, C. Bratton, N. Pilch, P. Baliga, K. Chavin

  • Early Emergence of De Novo Donor-Specific Antibody Is Associated with High Incidence of Acute Rejection in Kidney Transplant Recipients

    Y. Huang, D. Ramon, F. Luan, M. Samaniego

  • Early Experience with 3-Month Ciprofloxacin Prophylaxis for BK Infection in Renal Transplantation

    S. Patel, R. Knight, L. Moore, A. Lehnert, A. Agbetoba, J. DeVos, A. Gaber

  • Early Hospital Readmissions Following Kidney Transplant Are Associated with Inferior Patient Survival

    G. Dube, Y. Coppelson, D. Cohen, S. Mohan

  • Early Indicators of Kidney Graft Injury Mediated by Class II Donor Specific Antibodies (DSAII)

    E. Rodrigo, L. Cornell, B. Chopra, H. Amer, P. Dean, M. Stegall, F. Cosio

  • Early Inhibition of the Renin-Angiotensin System Improves Long-Term Graft Survival of Single Baby Kidneys Transplanted in Adults

    H. LaGuardia, A. Paramesh, M. Killackey, K. Mills, J. McGee, J. Buell, D. Slakey, B. Saggi, R. Zhang

  • Early Look at the OPTN Explant Pathology Form Data, An

    A. Harper, E. Edwards, J. Heimbach, R. Hirose, R. Freeman, K. Olthoff

  • Early Look at Transplant Outcomes from the OPTN KPD Pilot Program: Comparing Cold Times and DGF Rates with Other Living and Deceased Donor Transplants, An

    R. Leishman, R. Formica, K. Andreoni, J. Friedewald, E. Sleeman, C. Monstello, D. Stewart, T. Sandholm

  • Early Protocol Biopsies Can Identify Antibody-Mediated Rejection in Sensitized Patients

    P. Souza, D. Machado, A. Aguirre, D. David, E. Barbosa, F. de Paula, W. Nahas, E. David-Neto, M. Castro

  • Early Recurrence of Hepatocellular Carcinoma after Primary Liver Resection Is Associated with Poor Outcome of Salvage Liver Transplantation: A Multicenter Analysis of 82 Cases

    S. Lee, C. Kwon, S. Yang, H. Park, W. Cho, J. Kim, J. Park, S. Kim, J. Joh, B. Kim, H. Wang, K. Lee, K. Suh, S. Lee

  • Early Rehospitalization after Kidney Transplantation: Predictors and Prognosis

    M. Nair, E. Lin, A. Pai, M. Harhay, A. Huverserian, A. Mussell, A. Troxel, R. Bloom, M. Levine, P. Abt, J. Shea, P. Reese

  • Early Steroid Avoidance Reduces the Chance for a Subsequent Transplant in Renal Transplant Recipients with Graft Failure

    M. Casey, X. Wen, A. Santos, S. Rehman, H. Meier-Kriesche, J. Schold

  • Early Tubular Injury and Late Graft Dysfunction Associated with Cytomegalovirus Infection in Kidney Transplants

    L. Requião-Moura, E. Tonato, A. Matos, E. Arruda, R. Chinen, T. Filiponi, M. Durão jr, A. Pacheco-Silva

  • Echocardiographic Changes in Nondiabetic Kidney Transplant Recipients after Conversion from a Calcineurin Inhibitor to an Anti-mTOR Drug

    P. Ruiz-Esteban, D. Gaitan, V. Lopez, A. Maxuecos, D. Burgos, R. Collantes, E. Briceño, M. De Mora, D. Hernandez

  • Economic and Clinical Consequences of ABO Incompatible Kidney Transplantation: A National Database Study, The

    C. Simpkins, K. Lentine, H. Xiao, M. Schnitzler, J. Tuttle-Newhall, D. Segev, V. Dharnidharka, D. Brennan, D. Axelrod

  • Economic Impact of Pulsatile Hyothermic Perfusion in an Expanded Criteria Donor Transplant Program. Analysis of the First Year Implementation

    V. Gómez, V. Diéz, C. Galeano, A. Gomis, V. Hevia, M. Jiménez, R. Rodriguez-Patrón, F. Arias, C. Quereda, F. Burgos

  • Eculizumab (Anti-C5) for Treatment of Severe Antibody-Mediated Rejection (ABMR) and Recurrent C3 Glomerulonephritis in Renal Allografts: A Single Center Experience

    S. Jordan, J. Choi, R. Villicana, A. Peng, J. Kahwaji, R. Najjar, A. Vo

  • Eculizumab Efficacy in aHUS Pts with Progressing TMA, with or without Prior Renal Transplant

    C. Legendre, L. Greenbaum, N. Sheerin, D. Cohen, A. Gaber, F. Eitner, Y. Delmas, R. Furman, T. Feldkamp, D. Fouque, C. Bedrosian, C. Loirat

  • Eculizumab in aHUS Pts with Long Disease Duration, with or without Renal Transplant

    C. Legendre, C. Licht, M. Hourmant, Y. Delmas, M. Herthelius, A. Trivelli, T. Goodship, H. Haller, B. Moulin, C. Bedrosian, C. Loirat

  • Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplantation: An Interim Assessment

    S. Kulkarni, N. Kirkles-Smith, R. Tomlin, R. Formica, G. Moeckel, J. Pober

  • Effect of Adipose Tissue Derived Mesenchymal Stem Cells on B Cells Proliferation and Differentiation, The

    M. Franquesa, F. Mensah, R. Huizinga, M. Betjes, W. Weimar, C. Baan, M. Hoogduin

  • Effect of ASP0028 in Combination with Tacrolimus on Kidney Transplantation in Cynomolgus Monkeys, The

    L. Song, A. Ma, H. Dun, Y. Hu, L. Zeng, J. Bai, G. Zhang, K. Koide, Y. Okada, K. Hanaoka, Y. Otsuka, R. Yamamoto, J. Hirose, T. Morokata, H. Harada, N. Seki, P. Daloze, H. Chen

  • Effect of Belatacept on Follicular Helper T Cell and Humoral Response in Sensitized Rhesus Macaques, The

    J. Kwun, E. Page, A. Gibby, N. Iwakoshi, S. Knechtle

  • Effect of C1-Esterase Inhibitor (Human) on a Murine Acute Liver Failure Model, The

    R. Saidi, B. Rajeshkumar, O. Walter, A. Shariftabrizi, K. Dresser, B. Movahedi, N. Jabbour, A. Bozorgzadeh

  • Effect of C1-Esterase Inhibitor (Human) on Liver Ischemia-Reperfusion Injury and Regeneration, The

    R. Saidi, B. Rajeshkumar, O. Walter, A. Shariftabrizi, K. Dresser, B. Movahedi, N. Jabbour, A. Bozorgzadeh

  • Effect of Ciprofloxacin Prophylaxis on BK Virus Infection after Renal Transplantation

    D. Min, D. Vu, B. Kawewat, J. Poulsen, R. Naraghi, I. Hutchinson, T. Shah

  • Effect of CTLA4-Ig on the Fate of Alloreactive Th17 Cells In Vivo, The

    M. McGrath, M. Yeung, S. Yang, N. Zaman, B. Snawder, N. Najafian

  • Effect of Donor Comorbidites on Patient Survival – Standard Criteria Donor Kidney Compared to Expanded Criteria Donor Kidney Transplantation

    A. Patel, L. Malinzak, M. Goggins, V. Karthikeyan, K. Venkat, M. Abouljoud

  • Effect of Donor Right Hepatectomy on Regeneration of the Liver and the Spleen

    D. Kim, G. Na, T. Hong, Y. Yoo

  • Effect of Drain Placement on the Rate of Wound Complications in Kidney Transplantation, The

    R. Sidebottom, A. Parsikia, P. Chang, Z. Berhane, S. Campos, K. Khanmoradi, R. Zaki, J. Ortiz

  • Effect of EGF and FSP1 Targeting of Nanoparticle Delivery of IL-10 and GM-CSF Following Acute Kidney Injury, The

    M. Tobin, M. O'Connor, E. Szilagyi, N. Capezio, L. Nuñez, R. Spretz, S. Noriega, A. Bartholomew

  • Effect of Gender on Transplant Outcomes: A Meta-Analysis, The

    Z. Guo, W. Ju, P. Wang, M. He, S. Deng, X. He

  • Effect of Goal Tacrolimus Levels on Renal Function over Five Years Post-Transplant

    J. Teuteberg, A. Scanlon, S. Weaver, R. Zomak, R. Kormos, C. Bermudez, D. McNamara, M. Shullo

  • Effect of Human Adipose Derive Mesenchymal Stem Cells on Acute Liver Failure Model in Murine, The

    R. Saidi, B. Rajeshkumar, O. Walter, A. Shariftabrizi, K. Dresser, B. Movahedi, N. Jabbour, A. Bozorgzadeh

  • Effect of Human Adipose Derive Mesenchymal Stem Cells on Liver Ischemia-Reperfusion Injury and Regeneration in Humanized Mice, The

    R. Saidi, B. Rajeshkumar, O. Walter, A. Shariftabrizi, K. Dresser, B. Movahedi, N. Jabbour, A. Bozorgzadeh

  • Effect of Induction Therapy with Thymoglobulin on Outcome in Hepatitis C Infected Kidney Transplant Recipients: A Single Center Experience

    J. Linatoc, Q. Ren, M. Behnke, M. Posner, A. King

  • Effect of Normothermic Machine Perfusion (NMP) Using Various Perfusates on the Hepatocellular and Biliary Epithelial Integrity in Porcine Donation after Cardiac Death (DCD) Models, The

    A. Nassar, Q. Liu, K. Farias, C. Tom, G. D'Amico, A. Bennett, K. Abu-Elmagd, C. Miller, J. Fung, C. Quintini

  • Effect of Nrf2-keap1 Pathway Activation on Human Pancreatic β Cells, The

    Y. Masuda, S. Li, A. Le, M. Hajighasemi-Ossareh, C. Foster, N. Vaziri, H. Ichii

  • Effect of Plasmapheresis on Angiotensin II Type I Receptor Antibody

    H. Eng, R. Montgomery, M. Leffell, A. Zachary

  • Effect of Pre-Transplant Serum Sodium on Survival Benefit of Liver Transplantation

    P. Sharma, D. Schaubel, N. Goodrich, R. Merion

  • Effect of Pretransplant Renal Replacement Therapy on Liver Transplant Outcomes

    E. Asham, M. Boktour, C. Frenette, H. Monsour, W. Suki, A. Gaber, R. Ghobrial

  • Effect of Prophylaxis Duration on the Incidence of CMV Viremia and Hospitalization Rates in D+/R- Kidney Transplant Recipients

    J. Sia, J. Westervelt, E. Lyden, C. Miles

  • Effect of Proteasom Inhibition with Bortezomib Associated with Steroids on the Decrease of HLA Antibodies before Transplantation

    O. Aubert, C. Suberbielle, R. Gauthe, E. Nnang, H. Francois, A. Durrbach

  • Effect of Sirtuin 1 Gene Expression on Mouse Islet Graft Survival, The

    Y. Kim, Y. Wee, M. Choi, J. Chang, C. Yun, D. Han

  • Effect of the Purinergic Inhibitor Oxidized-ATP in a Model of Islet Allograft Rejection

    A. Vergani, R. Bassi, F. D'Addio, C. Fotino, S. Tezza, R. Molano, A. Soleti, P. Maffi, A. Secchi, C. Ricordi, M. Sayegh, A. Pileggi, P. Fiorina

  • Effect of Transient BK Viremia after T-Cell Depleting Antibody Therapy in Kidney Transplant Recipients, The

    J. Sageshima, G. Ciancio, L. Chen, A. Mattiazzi, G. Guerra, W. Kupin, D. Roth, P. Ruiz, G. Burke III

  • Effect of Vasodilators on Organ Function during Normothermic Machine Perfusion of Porcine DCD Liver, The

    A. Nassar, Q. Liu, K. Farias, C. Tom, G. D'Amico, A. Bennett, K. Abu-Elmagd, J. Fung, C. Miller, C. Quintini

  • Effective Federal Advocacy: The Case for HIV-Infected Deceased Organ Donors

    B. Boyarsky, K. Gebo, P. Stock, D. Segev

  • Effectiveness in Kidney Donation of Uncontrolled Donation after Cardiac Death (UDCD) Program with Out-of-Hospital Deceased People

    A. Andrés, M. Molina, E. Gonzalez, A. Sevillano, E. Gutierrez, N. Polanco, L. Garcia Puente, M. Praga, C. Carriedo, J. Morales, A. Mateos

  • Effectiveness of Rituximab and Intravenous Immunoglobulin for the Treatment of Chronic Antibody Mediated Rejection in Kidney Transplant Recipients

    G. An, B. Chung, C. Park, B. Choi, Y. Kim, C. Yang

  • Effects of Everolimus and Tacrolimus Exposure on Efficacy and Renal Function in Liver Transplant Recipients at 24 Months in a Randomized Trial (H2304)

    L. Fischer, G. Kaiser, B. Koneru, L. Toselli, F. Durand, N. Heaton, K. Shetty, G. Dong, P. Lopez, G. Junge, J. Kovarik

  • Effects of Hepatic Impairment on Single and Multiple Oral Dose Pharmacokinetics of Voclosporin (VCS)

    L. Aspeslet, D. Freitag, R. Huizinga, P. Mayo, S. Ling, R. Foster

  • Effects of High Fat Breakfast, Low Fat Breakfast or Fasting on the Absorption of Voclosporin (VCS), The

    L. Aspeslet, D. Freitag, R. Huizinga, S. Ling, P. Mayo, R. Foster

  • Effects of Human Alpha-1-Antitrypsin (hAAT) Therapy in a Murine Model of Bilateral Kidney Ischemia-Reperfusion Injury

    L. Hilbrands, N. Maicas, J. van der Vlag, M. Bakker, M. Roos, C. Dinarello, L. Joosten

  • Effects of Locoregional Treatment and “Downstaging” on Long-Term Post-Liver Transplant Outcomes for Patients with Hepatocellular Carcinoma

    N. Dzebisashvili, C. Stark, G. Mezochow, A. Harper, E. Edwards, D. Axelrod, R. Freeman

  • Effects of Propranolol, Somatostatin and Terlipressin on Recovery from Posthepatectomy Hepatic Failure after 90% Partital Hepatectomy in Rats

    W. Ji, D. Kim, Y. Koo, S. Jung, Y. Yu, S. Suh

  • Effects of the Novel PKCθ Selective Inhibitor AS2521780 on Acute Rejection in Rats and Monkeys

    N. Chida, T. Kawashima, M. Tasaki, H. Matsuoka, M. Maeda, A. Tanaka, Y. Higashi

  • Effects of Various Therapeutic Levels of Tacrolimus on Early Post Transplant Outcomes

    S. Rehman, X. Wen, M. Casey, A. Santos, K. Andreoni

  • Effects of Viral Infection on Chronic Anti-Mediated Rejection, The

    B. Oh, R. Ruhil, O. Bulut, J. Kwun, A. Kirk, S. Knechtle, N. Iwakoshi

  • Efficacy and Safety of 3 vs. 6 Months of Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Moderate-Risk (D+/R+) Renal Transplant Recipients Receiving Antilymphocyte Antibody Induction Therapy

    S. Gabardi, R. Cross, K. DePiero, T. Dick, A. Maldonado, P. Maxwell, J. Nelson, J. Park, K. Ueda, R. Weng, E. Newkirk

  • Efficacy and Safety of Calcineurin Inhibitor Withdrawal in Living Donor Kidney Transplantation with Older Donors

    G. Chen, L. Chen, J. Qiu, C. Wang, J. Fei, S. Deng, J. Li, G. Huang, Q. Fu

  • Efficacy and Safety of Corticosteroid Withdrawal (CSW) in Kidney Transplant Recipients during Routine Practice: A Prospective, 4-Year Analysis from the Mycophenolic Acid Observational Renal Transplant (MORE) Study

    K. Ueda, A. Wiland, K. McCague, V. Ram Peddi

  • Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 4 Years Follow-Up Especially in Protocol Biopsy Findings and Donor Specific Antibody Production

    S. Narumi, Y. Watarai, T. Yamamoto, M. Tsujita, T. Hiramitsu, K. Nanmoku, N. Goto, A. Katayama, A. Takeda, K. Morozumi, K. Uchida, T. Kobayashi

  • Efficacy and Safety of Influenza Vaccination during the First Six Months Post-Transplantation

    E. Cordero, A. Bulnes-Ramos, T. Aydillo, B. Leon-Jimenez, J. Torre-Cisneros, R. Lara, J. Gavalda, M. Gentil, M. Gomez, E. Lage, P. Perez-Romero

  • Efficacy and Safety of Prolonged Valganciclovir Prophylaxis in Children after Living Donor Liver Transplantation

    T. Ueno, S. Ibuka, K. Masahata, M. Nomura, K. Nara, S. Uehara, H. Soh, T. Oue, H. Kondou, N. Usui

  • Efficacy and Safety of Renin Angiotensin Aldosterone System (RAAS) Blockade Immediately after Renal Transplantation

    C. Chatzikyrkou, J. Eichler, C. Clajus, J. Menne, F. Lehner, F. Helfriz, L. Kousoulas, W. Ramackers, H. Haller, M. Schiffer

  • Efficacy and Safety of Single Fixed-Dose Rituximab for Recurrent Glomerulonephritis Post-Transplantation

    M. Spinner, L. Bowman, T. Horwedel, R. Delos Santos, C. Klein, D. Brennan

  • Efficacy and Safety of Three Different Treatment Regimens in De Novo Renal Transplant Patients: Follow-Up Results of the HERAKLES Trial at Month 24

    M. Zeier, K. Budde, W. Arns, M. Guba, C. Sommerer, H. Neumayer, J. Jacobi, V. Kliem, C. May, D. Baeumer, E. Paulus, O. Witzke, F. Lehner

  • Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study

    K. Saito, K. Uchida, S. Takahara, N. Yoshimura, S. Teraoka, C. Cornu-Artis, E. Kobayashi, K. Takahashi

  • Efficient Identification of All Grades of Antibody Mediated Rejection (AMR) and Mixed Rejection with a Unique Immunohistochemical Panel in Heart Transplant Patients

    P. Ruiz, S. Chaparro, E. Bauerlein, T. Bueno, B. Bednar, P. Rusconi, J. Jimenez, S. Pham

  • Eighteen Months Follow-Up in Obese Recipients with Robotic Kidney Transplantation

    I. Tzvetanov, L. Bejarano-Pineda, P. Giulianotti, F. Bianco, S. Ayloo, J. Oberholzer, E. Benedetti

  • Elderly Patients with Cronic Renal Disease: Do They Deserve a Renal Transplant?

    P. Orlandi, M. Cristelli, C. Rodrigues, C. Felipe, H. Tedesco, J. Medina-Pestana

  • Elective Living Donor Liver Transplantation by Hybrid Hand-Assisted Laparoscopic Surgery with Short Upper Midline Laparotomy

    M. Takatsuki, A. Soyama, Y. Torashima, A. Kinoshita, T. Adachi, A. Kitasato, F. Fujita, K. Kanetaka, T. Kuroki, S. Eguchi

  • Elevated Tacrolimus Trough Concentrations Significantly Increase the Risk of New Onset Diabetes after Liver Transplantation

    R. Amarnath, D. Taber, N. Pilch, H. Meadows, J. Fleming, A. Mardis, K. Morbitzer, C. Jordan, C. Makowski, C. Bratton, J. McGillicuddy, P. Baliga, K. Chavin

  • Encapsulated Human Mesenchymal Stem Cells Reduce Alpha-Smooth Muscle Actin and Increase Matrix Metalloproteinase-9 Expression during Liver Fibrosis

    R. Meier, R. Mahou, P. Morel, Y. Muller, P. Christofilopoulos, C. Wandrey, C. Gonelle-Gispert, L. Buhler

  • Endodermal Precursor Cells Derived from Embryonic Stem Cells Can Engraft in Mouse Liver

    N. Liu, J. Fair

  • Endogenous Memory CD8 T Cells Are Activated To Proliferate and Express Effector Functions within Cardiac Allografts without Mediating Rejection

    S. Iida, K. Setoguchi, Y. Hattori, C. Su, W. Baldwin III, K. Tanabe, R. Fairchild

  • Endothelial Cell Reactive Antibodies: Antigenic Targets and Mechanism of Action

    A. Jackson, T. Sigdel, S. Bagnasco, R. Montgomery, M. Sarwal

  • Endothelial Proliferation Precedes the Development of Endothelial-To-Mesenchymal Transition (EndMT)

    C. Woda, S. Bruneau, D. Briscoe

  • Endothelial-to-Mesenchymal Transition Contributes to Cardiac Allograft Rejection and Vasculopathy

    Y. Xiao, Z. Mao, H. Liu

  • Endourological Management of Urolithiasis in Living Donor Transplant Kidneys

    M. Takata, S. Ashimine, T. Yamamoto, M. Tsujita, T. Hiramitsu, N. Goto, K. Nannmoku, Y. Watarai, T. Kobayashi

  • Energy Status of Pig Donor Organs after Ischemia Is Independent of Donor Type

    M. Sereinigg, A. Puntschart, V. Stadlbauer, F. Iberer, B. Leber, K. Tscheliessnigg, G. Jürgens, T. Sefert-Held, S. Hallström, P. Stiegler

  • Enhanced Liver Regeneration in Mice Lacking the Chemokine Receptor CCR5

    C. Gonelle-Gispert, S. Sorce, P. Morel, R. Meier, S. Lacotte, D. Bosco, L. Buhler

  • Enhancement of Cardiovascular Differentiation Induced by Leptin in Embryonic Stem Cells

    S. Kurtovic, D. Dafoe, T. Ng, K. Chaiboonma, M. Aminzadeh, R. Makkar, D. Talavera-Adame

  • Enoxaparin Targets Heparanase To Elicit Its Anti-Metastatic Activity

    S. Djaafar, G. Mentha

  • Enterococcal Colonization and Disease in Solid-Organ Versus Hematologic Malignancy and Hematopoietic Stem Cell Transplantation Units (2000–2011)

    A. Safdar, G. Tulliano, L. Teperman, R. Press

  • Epidemiology and Prevention Approaches for Cytomegalovirus (CMV) Disease in CMV-Seropositive Kidney Transplant (KT) Recipients: Results from a Multicenter, Prospective, Cohort Study (OPERA Study)

    J. Aguado, M. Fernández-Ruiz, M. Arias, J. Campistol

  • Epigenetic Analysis of the TSDR of FOXP3 Demonstrates That Natural Treg Infiltrate the Cardiac Allograft Already before an Acute Rejection Episode

    K. Boer, A. Peeters, A. Maat, K. Caliskan, A. Balk, W. Weimar, C. Baan

  • Epigenetic Approach for Standardized and Quantitative Analysis of Renal Allograft Biopsies: Acute Cellular Rejection Is Characterized by Infiltration of Th17 and Treg Cells

    N. Babel, U. Baron, C. Rosenberger, R. Schindler, M. Dziubianau, A. Sefrin, S. Olek, P. Reinke

  • Epigenetic Mechanisms Underlying Allograft Rejection: Role of the Histone Acetyltransferase, GCN-5 in T Cell Activation, Proliferation and Cytokine Production

    C. Bao, Y. Liu, L. Wang, R. Han, S. Dent, W. Hancock

  • Epithelial-to-Mesenchymal Transition and Tacrolimus Toxicity in Renal Transplant Recipient

    J. Bloch, F. Glowacki, C. Cauffiez, D. Buob, C. Noel, C. Van Der Hauwaert, M. Hazzan

  • Epitope Analysis of col(V)-Specific Th17 Cell Responses in Lung Transplantation Reveals an HLA-DRB1*1501 Bias in Both Patient and Donor

    W. Burlingham, M. Keller, L. Haynes, E. Gan, V. Agashe, G. Leverson

  • Epitope Matching Outperforms Traditional Antigen Matching as a Predictor of De Novo Donor Specific Antibody Development after Renal Transplantation

    C. Wiebe, D. Pochinco, T. Blydt-Hansen, I. Gibson, D. Rush, P. Nickerson

  • Epitope Spreading and Epitope Sharing Are Involved in Acute IgG1 Antibody-Mediated Rejection of a Kidney Transplant with Disparity Only at HLA-DP

    B. Mierzejewska, P. Schroder, C. Baum, A. Blair, R. Duquesnoy, M. Marrari, M. Rees, S. Stepkowski

  • ES Cell-Derived Hematopoietic Progenitor Cells Downregulate Alloreactive T Cells Using Arginase 1

    E. Kim, B. Miyake, M. Aggarwal, N. Zavazava

  • Esophageal Eosinophilia after Intestinal Transplantation

    K. Khan, C. Desai, R. Girlanda, E. Island, C. Matsumoto, T. Fishbein, S. Kaufman

  • Essential Role of CBP in Maintaining Foxp3 Stability during Inflammatory Events

    Y. Liu, L. Wang, C. Bao, U. Beier, R. Han, H. Xiao, P. Brindle, W. Hancock

  • Establishment of Limited Sampling Strategy for the Estimation of Once-Daily Extended-Release Formulation of Tacrolimus Exposure in Adult Kidney Transplant Recipients

    H. Harada, K. Achiwa, N. Fukuzawa, Y. Yuki, K. Hotta, T. Seki, M. Togashi

  • Establishment of New Methods for Chronic Antibody Mediated Renal Rejection Model with Clinical Immunosuppressive Drugs in Non-Human Primates

    M. Maeda, S. Tsujimoto, H. Fukahori, S. Oshima, K. Nakamura, T. Marui, Y. Higashi, N. Seki, W. Uchida

  • Estimated Glomerular Filtration Rate Decreases Transiently Following Repeat Heart Transplantation in Children and Young Adults

    J. Gralla, S. Auerbach, C. Connell, M. Mitchell, D. Campbell, J. Jaggers, S. Miyamoto, B. Pietra

  • Evaluation of an Immunomodulation Program Utilizing IVIG as a Single Agent vs. Combination Therapy with IVIG and Rituximab

    T. Taber, M. Mujtaba, W. Goggins, N. Higgins, A. Sharfuddin, M. Yaqub, D. Mishler, B. Book, J. Chen, A. Lobashevsky

  • Evaluation of Cystic Growth in ADPKD Renal Transplant Recipients Following Conversion to an mTOR Inhibitor

    J. Mandabach, M. Rees, H. Elsamaloty, L. Gowharji, L. Twining, S. Khuder, S. Ratnam

  • Evaluation of Humoral (HI) & Cell-Mediated Immune (CMI) Responses to Trivalent Influenza Vaccine (TIV) Administered Early after Solid-Organ Transplantation (SOT)

    S. Taimur, L. Danziger, R. Avery, T. Fitzgerald, E. Poggio, C. Koval

  • Evaluation of Immunocompetence in Tolerant Chimeric Recipients of Hematopoietic Stem Cell/Renal Transplants

    J. Leventhal, L. Bozulic, M. Badder, M. Elliott, M. Ison, S. Ildstad

  • Evaluation of Low-Dose Rituximab Treatment; the Incidence of Graft Rejection and Adverse Events in 313 Living Kidney Transplant Recipients

    T. Hirai, H. Ishida, K. Omoto, T. Nozaki, T. Shimizu, M. Furusawa, K. Tanabe

  • Evaluation of Non-Adherence in Patients Undergoing Dialysis, Pre- and Post-Kidney Transplantation: US Transplant Practice Patterns Survey

    A. Brar, M. Salifu, R. Jindal

  • Evaluation of Sexual Functions in Females Receiving Renal Replacement Therapies

    R. Demir, Y. Bostanci, F. Atac, E. Ozden, C. Kaya, S. Sarikaya, Y. Yakupoglu

  • Everolimus (RAD001) Treatment Effect in Liver Transplantation – A Rational Approach To Quantify the mTOR Effect

    G. Junge, T. Dumortier, L. Fischer, S. Kohler, J. Fung

  • Everolimus Aggravates Tacrolimus-Induced Pancreatic Injury by Pharmacologic Interaction between Everolimus and Tacrolimus

    S. Piao, S. Lim, K. Doh, L. Jin, B. Chung, S. Heo, C. Yang

  • Everolimus Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients: 12-24 Month Data from North America

    W. Chapman, R. Brown Jr, D. Sudan, K. Chavin, B. Koneru, M. Huang, G. Junge, J. Hexham, G. Dong, A. Wiland, J. Fung

  • Everolimus-Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients Achieves Comparable Overall Efficacy with Fewer Biopsy-Proven Acute Rejections Versus Standard Tacrolimus: 24-Month Results of a Randomized Trial

    J. Fung, K. Chavin, Y. Moysyuk, S. Orloff, S. Yantorno, R. Jones, P. Neuhaus, G. Dong, P. Lopez, G. Junge, F. Nevens

  • Evidence for Chronic Rejection of the Skin and Adnexal Structures in a Hand Transplant Recipient at Six Years Post Transplant without Significant Graft Vasculopathy

    C. Kaufman, M. Marvin, R. Ouseph, Y. Manon-Matos, B. Blair, J. Kutz

  • Evidence for Decreased Cellular and Humoral Renal Allograft Rejection in Combined Liver-Kidney Transplants

    T. Taner, J. Heimbach, C. Rosen, Z. El-Zoghby, M. Stegall

  • Evidence for Renal Tubular Epithelial Cells as Another Source of IL-17 Producing Cells

    H. Zhou, L. Xue, Y. Wang, J. Liu, L. Zhang, J. Yu

  • Evidence That Anti-Interleukin-6 Receptor Treatment Modulates Splenic T-Cell Subsets during Development of Allosensitization

    I. Kim, G. Wu, N. Chai, S. Jordan, A. Klein

  • Evolution in Kidney Transplant Recipients of the Expression of Skin-Homing Receptors in the Different CD4+ T Cell Subsets Obtained by Aspiration Cytology of the Renal Graft Versus Peripheral Blood

    A. Caballero, P. Ruiz-Esteban, M. Leon, E. Palma-Merida, D. Burgos, M. Cabello, M. Gonzalez-Molina, A. Torres, D. Hernandez

  • Evolution of SPK Transplant in Type I and Type II Diabetics with End Stage Renal Disease: The 20 Year Experience, The

    J. Light, M. Tucker, M. Orquiza

  • Evolving Face of Liver Donors: Updating the Donor Risk Index, The

    J. Lai, E. Vittinghoff, S. Feng

  • Evolving Trends in Living Donor Uninephrectomy Techniques and Impact on Post-Transplant Outcomes: A Review of the US National Cohort

    J. Verbesey, M. Grafals, M. Cooper, J. Moore, S. Ghasemian, C. Nilubol, B. Javaid

  • Ex Vivo Expanded Human Regulatory T Cells Are Potent Suppressors but May Be Short-Lived

    S. Gupta, P. Samuels, S. Long, M. Tatum, J. Buckner

  • Ex Vivo-Expanded Non-Human Primate Regulatory T Cells Are Resistant to Alemtuzumab-Mediated, Complement-Dependent Cytotoxicity

    E. Dons, G. Raimondi, H. Zhang, J. Bhama, L. Tu, M. Ezzelarab, J. IJzermans, D. Cooper, A. Thomson

  • Ex-Vivo Generation of Immunosuppressive Human Cells by Co-Culture of Recipient and Irradiated Donor PBMCs under CD80/CD86 Costimulation Blockade

    A. Nagatsu, K. Yamashita, M. Zaitsu, S. Emoto, Y. Asahi, M. Ogura, H. Ono, Y. Tsunetoshi, R. Goto, R. Igarashi, H. Bashuda, K. Okumura, A. Taketomi, S. Todo

  • Examination of Infectious Complications with Plasmapheresis in Combination with Anti-Thymocycte Globulin for the Treatment of Acute Rejection

    A. Hulbert, A. Rajab, J. Von Visger, H. Winters

  • Excellent Liver Transplant Outcomes in Patients with Coronary Artery Disease

    C. Frenette, M. Boktour, H. Jhun, A. Bhimaraj, J. Estep, E. Asham, H. Monsour, A. Gaber, R. Ghobrial

  • Excellent Long-Term Outcome of ABO-Incompatible Living Donor Kidney Transplantation; a Single Center Experience for over 20 Years

    T. Nozaki, H. Ishida, T. Shimizu, K. Omoto, H. Shirakawa, T. Hirai, M. Furusawa, K. Tanabe

  • Excellent Outcome Following Transplant Using Kidneys from Deceased Donors with Severe Acute Kidney Injury

    R. Heilman, H. Khamash, J. Huskey, M. Smith, N. Katariya, A. Moss, D. Mulligan, K. Reddy

  • Excellent Outcomes of Kidney Transplant in Patients with Bipolar Disorder

    G. Dube, R. Crew, D. Tsapeppas, F. Khorassani, I. Wiener

  • Excellent Outcomes with Transplantation of Kidneys (KTx) from Deceased Donors (DDs) with Acute Kidney Injury (AKI)

    C. Santhanakrishnan, A. De Mattos, J. McVicar, R. Perez, C. Troppmann

  • Excellent Results of Living-Related Renal Transplant Recipients Treated with High-Dose Mizoribine – Two Years Result of a Japanese Multicenter Study

    N. Yoshimura, K. Uchida, K. Yuzawa, Y. Fukuda, K. Akioka, M. Fujisawa, S. Lto, T. Nakatani, T. Horimi, H. Ushigome, K. Nishimura

  • Exogenous Hydrogen Sulphide Mitigates Long-Term Renal Dysfunction Associated with Warm Renal Ischemia-Reperfusion Injury

    J. Zhu, I. Lobb, W. Liu, B. Garcia, Z. Lan, A. Sener

  • Expanding the Deceased Donor Pool

    D. Adey, R. Perez, M. Alnimri, A. de Mattos

  • Expanding the Limits of the Expanded Criteria Donor

    L. Assis, M. Cristelli, T. Claudia, S. Miranda, M. Franco, T. Sandes-Freitas, M. Salenave, H. Tedesco, J. Medina- Pestana

  • Expansion and Differentiation of B Cell Clones in Rejected Kidney Grafts

    J. Ferdman, F. Porcheray, C. Moore, B. Gao, J. DeVito, S. Tullius, T. Kawai, W. Wong, E. Zorn

  • Expedited Liver Allocation in the U.S.: A Critical Analysis

    P. Gaglio, J. Lindower, A. Principe, R. John, M. Kinkhabwala

  • Experience with Linezolid (LZD) for the Treatment of Nocardiosis in Solid Organ Transplant Recipients (SOT)

    O. De la Cruz, L. Minces, F. Silveira

  • Experience with Sorafenib in the Liver Transplant Population

    E. Cahan, B. Gelb, R. Mittal, G. Morgan, A. Goldenberg, L. Teperman

  • Exploring the Role of Embryonic Liver Development Genes in HCV Induced Cirrhosis and Hepatocellular Carcinoma

    M. Behnke, M. Reimers, R. Fisher

  • Expression of the Transcriptional Regulator snail1 in Kidney Transplants with Epithelial to Mesenchymal Transition Features

    Y. Dubois-Xu, P. Galichon, I. Brocheriou, E. Baugey, C. Jouanneau, N. Ouali, E. Rondeau, A. Hertig

  • Extended Criteria Donor (ECD) Renal Allograft Use in Older Recipients in a Short Wait Time Center: Is There an Advantage?

    K. Andreoni, J. Gregg, I. Zendejas, S. Rehman, B. Boland, M. Casey, A. Santos, J. Fair

  • Extended-Release Tacrolimus Plus Everolimus vs Extended-Release Tacrolimus Plus Micophenolate Mofetil in Primary Deceased Donor Kidney Transplant Recipients: 1-Year Results of an Open Label, Randomized Phase 2 Clinical Trial

    E. Favi, N. Silvestrini, J. Pedroso, M. Salerno, G. Spagnoletti, V. Bianchi, J. Romagnoli, F. Citterio

  • Extended-Release Tacrolimus Therapy Is Effective and Safe in De Novo Kidney Transplant Recipients from Living and Expanded, Standard, or after Cardiac Death Deceased Donors

    A. Andrés, E. Gonzalez, N. Polanco, L. Garcia-Puente, J. Morales, M. Molina, E. Gutierrez-Solis, A. Hernandez, A. Sevillano, M. Praga

  • Extent and Drivers of Geographic Inequity in Kidney Transplantation in the United States, The

    A. Davis, S. Mehrotra, J. Friedewald, A. Skaro, L. McElroy, R. Kang, J. Holl, M. Abecassis, D. Ladner

  • Extent of Donor Smoking and Mid-Term Outcomes after Lung Transplantation – A Single Center Analysis

    A. Sabashnikov, D. Garcia, P. Mohite, B. Zych, M. Capoccia, A. Popov, A. Moza, F. De Robertis, M. Amrani, T. Barahmi, M. Carby, A. Reed, A. Simon

Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences